Tower Research Capital (TRC)’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7K | Sell |
945
-1,487
| -61% | -$2.68K | ﹤0.01% | 4760 |
|
|
2025
Q1 | $4.65K | Buy |
+2,432
| New | +$4.65K | ﹤0.01% | 4222 |
|
|
2024
Q4 | – | Sell |
-4,842
| Closed | -$8.62K | – | 5792 |
|
|
2024
Q3 | $8.62K | Buy |
4,842
+3,113
| +180% | +$5.54K | ﹤0.01% | 3948 |
|
|
2024
Q2 | $2.21K | Sell |
1,729
-2,903
| -63% | -$3.72K | ﹤0.01% | 5040 |
|
|
2024
Q1 | $17.5K | Sell |
4,632
-260
| -5% | -$980 | ﹤0.01% | 3122 |
|
|
2023
Q4 | $16K | Buy |
4,892
+2,022
| +70% | +$6.6K | ﹤0.01% | 3798 |
|
|
2023
Q3 | $9.41K | Sell |
2,870
-1,477
| -34% | -$4.85K | ﹤0.01% | 4221 |
|
|
2023
Q2 | $19.5K | Sell |
4,347
-2,497
| -36% | -$11.2K | ﹤0.01% | 3382 |
|
|
2023
Q1 | $33K | Sell |
6,844
-308
| -4% | -$1.49K | ﹤0.01% | 2893 |
|
|
2022
Q4 | $23K | Buy |
7,152
+1,891
| +36% | +$6.08K | ﹤0.01% | 2992 |
|
|
2022
Q3 | $17K | Buy |
5,261
+4,545
| +635% | +$14.7K | ﹤0.01% | 4064 |
|
|
2022
Q2 | $3K | Buy |
716
+123
| +21% | +$515 | ﹤0.01% | 5374 |
|
|
2022
Q1 | $2K | Sell |
593
-577
| -49% | -$1.95K | ﹤0.01% | 5548 |
|
|
2021
Q4 | $7K | Buy |
1,170
+615
| +111% | +$3.68K | ﹤0.01% | 4909 |
|
|
2021
Q3 | $4K | Buy |
555
+483
| +671% | +$3.48K | ﹤0.01% | 4970 |
|
|
2021
Q2 | $0 | Buy |
+72
| New | – | ﹤0.01% | 5595 |
|